Topic: Biotech
As attempts to reform and improve the American health care system plod forward, little is said about giving patients more tools to manage their own health and wellness. Rajiv Mehta and Hugh Dubberly, applying their imagination as designers, suggest tools for patients to design their own treatment and improve personal well-being.
Dr. Moira Gunn shares insight with Eric Thomlinson, President and CEO of Altea Therapeutics, about their new devices for injecting drugs, without the use of a needle.
Dr. Moira Gunn speaks with the President of Regulus Therapeutics, Kleanthis Xanthopolous, about his companies work in the field of micro RNA, it's role in disease and how it may provide an opportunity for treatment.
Dr. Moira Gunn and David Ewing Duncan talk personalized medicine with Wired magazine Executive Editor, Thomas Goetz.
Dr. Moria Gunn talks with author, David Shenk, about his book, The Genius in All of Us: Why Everything You've Been Told about Genetics, Talent and IQ is Wrong, reviewed by the New York Times Book Review as 'a deeply interesting and important book.'
Dr. Moira Gunn visits Syntaxin Ltd. CFO, Phil Boyd to talk about all things Botox.
Dr. Moira Gunn connects with author and BioIssue correspondent, David Duncan about the big business of pharmaceuticals.
Dr. Moira Gunn discusses food safety with Mike Doyle, Director of the Center for Food Safety at the University of Georgia. They dive into the challenge, prefaced by the statistic that 15% of our food is imported from other countries.
Dr. Moria Gunn talks with Dr. Tom Shepherd, CEO of Scottish firm, CXR Biosciences, about their work adding select genetic switches to lab mice.
Dr. Moria Gunn learns about the uses for chemical genomics from Dr. Greg Roth, Director of Medicinal Chemistry from the Burnham Institute for Medical Research. She then sits down with GeoVax Labs Senior VP, Dr. Harriet Robinson, where they study HIV and AIDS vaccines.
